Fainting-like spells very 2-10mins for 3 hours - 1.5 hour after 1. vaccine, 13mins; oversensitivity to "sugar hole" after some meals; electrical flash in brain after watching TV; dizziness when reading on mobile and scrolling or switching windows on computer; dizziness when reading glossy pages; erratic blood pressure: increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55); increased heart rate by 20-30 points; heart palpitations/adrenaline-like rushes when falling asleep; increased body temperature by 1-2 degrees; dermatitis-like rash when back of hands dry; Suspected vestibular migraine; overactive stress response and sensory overload, sensitivity to light, sound, temperature change and smell causing dizziness; sensory overload; sensitivity to light; sensitivity to sound; erratic blood pressure: increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55); heart palpitations/adrenaline-like rushes when falling asleep; dermatitis-like rash when back of hands dry; increased water intake to 4-5 quarts per day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Apr2021 at 08:30 as dose 1, single (Lot number: EW0172) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "low blood pressure" (unspecified if ongoing); "Endometriosis" (unspecified if ongoing); "Migraines" (unspecified if ongoing), notes: (25+years); "Meningioma" (unspecified if ongoing). Concomitant medication(s) included: LEVONORGESTREL intra-uterine. The following information was reported: SYNCOPE (disability, medically significant) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "Fainting-like spells very 2-10mins for 3 hours - 1.5 hour after 1. vaccine, 13mins"; VESTIBULAR MIGRAINE (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "Suspected vestibular migraine"; RASH (disability), DRY SKIN (disability) all with onset 18Apr2021 at 10:00, outcome "not recovered" and all described as "dermatitis-like rash when back of hands dry"; DIZZINESS (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "dizziness when reading on mobile and scrolling or switching windows on computer; dizziness when reading glossy pages"; FEELING ABNORMAL (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "electrical flash in brain after watching TV"; BLOOD PRESSURE FLUCTUATION (disability), FATIGUE (disability) all with onset 18Apr2021 at 10:00, outcome "not recovered" and all described as "erratic blood pressure: increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55)"; AGITATION (disability), PALPITATIONS (disability) all with onset 18Apr2021 at 10:00, outcome "not recovered" and all described as "heart palpitations/adrenaline-like rushes when falling asleep"; BODY TEMPERATURE INCREASED (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "increased body temperature by 1-2 degrees"; HEART RATE INCREASED (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "increased heart rate by 20-30 points"; POLYDIPSIA (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "increased water intake to 4-5 quarts per day"; STRESS (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "overactive stress response and sensory overload, sensitivity to light, sound, temperature change and smell causing dizziness"; FOOD ALLERGY (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "oversensitivity to "sugar hole" after some meals"; PHOTOPHOBIA (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "sensitivity to light"; HYPERACUSIS (disability) with onset 18Apr2021 at 10:00, outcome "not recovered", described as "sensitivity to sound"; SENSORY OVERLOAD (disability) with onset 18Apr2021 at 10:00, outcome "not recovered". The events "fainting-like spells very 2-10mins for 3 hours - 1.5 hour after 1. vaccine, 13mins", "oversensitivity to "sugar hole" after some meals", "electrical flash in brain after watching tv", "dizziness when reading on mobile and scrolling or switching windows on computer; dizziness when reading glossy pages", "erratic blood pressure: increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55)", "increased heart rate by 20-30 points", "heart palpitations/adrenaline-like rushes when falling asleep", "increased body temperature by 1-2 degrees", "dermatitis-like rash when back of hands dry", "suspected vestibular migraine", "overactive stress response and sensory overload, sensitivity to light, sound, temperature change and smell causing dizziness", "sensory overload", "sensitivity to light", "sensitivity to sound" and "increased water intake to 4-5 quarts per day" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: erratic; Increased blood pressure by 20-30 points, notes: Increased blood pressure by 20-30 points during most part of a day or too low when tired or after meals (85/55); Body temperature: increased body temperature by 1-2 degrees; Heart rate: increased heart rate by 20-30 points. Therapeutic measures were taken as a result of syncope, food allergy, feeling abnormal, dizziness, blood pressure fluctuation, heart rate increased, agitation, body temperature increased, rash, vestibular migraine, stress, sensory overload, photophobia, hyperacusis, fatigue, palpitations, dry skin, polydipsia. Clinical course: If covid prior vaccination: No. The patient did not received covid test post vaccination. The patient received other medications in two weeks: Liletta UID (Levonorgestrel-Releasing Intrauterine. The patient received treatment with Meclizine, B2 vitamin.  Follow-up attempts are completed. No further information is expected.